Blackstone Life Sciences and Novartis launch Anthos Therapeutics to target high-risk cardiovascular diseases

In a strategic partnership aimed at advancing cardiovascular treatments, Blackstone Life Sciences has teamed up with Swiss pharmaceutical giant Novartis to create Anthos Therapeutics, a ... Read More